Ertumaxomab
Modify Date: 2024-04-08 17:35:11
Ertumaxomab structure
|
Common Name | Ertumaxomab | ||
|---|---|---|---|---|
| CAS Number | 509077-99-0 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of ErtumaxomabErtumaxomab (Anti-Human CD22 Recombinant Antibody) is a bispecific antibody targeting HER2/neu and CD3. Ertumaxomab activates Fcγ type I/III-receptors, forming a tri-cell complex among tumour cell, T cell and accessory cell. Ertumaxomab has been used to research breast cancer[1]. |
| Name | Ertumaxomab |
|---|
| Description | Ertumaxomab (Anti-Human CD22 Recombinant Antibody) is a bispecific antibody targeting HER2/neu and CD3. Ertumaxomab activates Fcγ type I/III-receptors, forming a tri-cell complex among tumour cell, T cell and accessory cell. Ertumaxomab has been used to research breast cancer[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |